Purdue Pharma L.P. v. Iancu

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit

______________________

PURDUE PHARMA L.P., P.F. LABORATORIES, INC., PURDUE PHARMACEUTICALS L.P., Appellants

v.

ANDREI IANCU, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, Intervenor

______________________

2018-1285, 2018-1286

______________________

Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2016- 01027, IPR2016-01028.

______________________

JUDGMENT

______________________

JENNIFER LORAINE SWIZE, Jones Day, Washington, DC, argued for appellants. Also represented by ROBERT STANDER, GREGORY A. CASTANIAS; GASPER LAROSA, JOHN JOSEPH NORMILE, JR., New York, NY.

SARAH E. CRAVEN, Office of the Solicitor, United States

Patent and Trademark Office, Alexandria, VA, argued for intervenor. Also represented by THOMAS W. KRAUSE, MARY L. KELLY, JOSEPH MATAL.

______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (DYK, MAYER, and BRYSON, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

April 4, 2019 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court